Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

OncoSec Medical Incorporated (ONCS)

  • Company Report
  • Dec. 16, 2022, 01:00 UTC
  • 44

New SEC Form for OncoSec Medical Incorporated

Comment Full text

Sonnet BioTherapeutics Holdings Inc. (SONN)

  • Company Report
  • Dec. 16, 2022, 00:40 UTC
  • 39

New SEC Form for Sonnet BioTherapeutics, Inc.

Comment Full text

Moleculin Biotech Inc. (MBRX)

  • Company Report
  • Dec. 15, 2022, 16:50 UTC
  • 43

Moleculin Biotech, Inc. SEC filing

Comment Full text

Rigel Pharmaceuticals Inc (RIGL)

  • Company Report
  • Dec. 15, 2022, 16:10 UTC
  • 44

Rigel Doses First Patient in Phase 1b Study of R289 for the Treatment of Lower-Risk Myelodysplastic Syndromes

Comment Full text

PharmaCyte Biotech Inc. (PMCB)

  • Company Report
  • Dec. 15, 2022, 01:25 UTC
  • 39

New SEC Form for PharmaCyte Biotech, Inc.

Comment Full text

Applied DNA Sciences Inc. (APDN)

  • Company Report
  • Dec. 15, 2022, 00:15 UTC
  • 44

Applied DNA Sciences SEC filing

Comment Full text

Cytokinetics Inc (CYTK)

  • Company Report
  • Dec. 13, 2022, 15:05 UTC
  • 43

Cytokinetics Stock Trading Halted Today

Comment Full text

ADMA Biologics Inc (ADMA)

  • Company Report
  • Dec. 13, 2022, 15:05 UTC
  • 44

ADMA Biologics Announces FDA Approval for Room Temperature Storage ofASCENIV™ & BIVIGAM®

Comment Full text

Abcam Plc (ABCM)

  • Company Report
  • Dec. 09, 2022, 20:36 UTC
  • 44

Abcam Plc Notification

Comment Full text

Cytokinetics Inc (CYTK)

  • Company Report
  • Dec. 09, 2022, 17:05 UTC
  • 46

Cytokinetics Announces Availability of Briefing Documents for FDA Advisory Committee Meeting on Omecamtiv Mecarbil

Comment Full text
  • Previous
  • 38
  • 39
  • 40
  • 41
  • 42
  • Next

Search

News categories

  • Technical Exchange News(9318)
  • Event(407)
  • SEC News(151471)
  • FDA Approval(8687)
  • Company Report(721)
  • Business News(103888)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin